Article

Incidence and Nature of Adverse Events Following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination Strategy

2024-01-03

Abstract excerpt

This study evaluates the incidence and characteristics of adverse events (AEs) following the second COVID-19 booster dose, leveraging Taiwan's distinctive approach of extending booster vaccinations to all citizens, unlike the targeted high-risk group strategies in other countries. Utilizing data from Taipei Veterans General Hospital's Vaccine Adverse Event Reporting System (VAERS) from October 27, 2022,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 066f5bf3-3337-585a-9999-2cbfb0a42f27
DOI: 10.20944/preprints202401.0101.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Incidence and Nature of Adverse Events Following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination StrategyDOI 10.20944/preprints202401.0101.v1Read

An objective systematic comparison of the most common adverse events of COVID-19 vaccinesSemantic proximity Read

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceSemantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

Safety of the Fourth COVID-19 BNT162b2 mRNA (Second Booster) VaccineSemantic proximity Read

Exploring Temporal and Spatial Characteristics of Serious Adverse Event Reports Following COVID-19 Bivalent VaccinesSemantic proximity Read

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO databaseSemantic proximity Read

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read

Contextualizing adverse event following immunization data of coronavirus disease 2019 (COVID-19) vaccines in VigiAccess: An approach for reducing COVID-19 vaccine hesitancySemantic proximity Read

Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergySemantic proximity Read

Heterologous prime-boost immunization with CoronaVac and ConvideciaSemantic proximity Read

Durability of protection post-primary COVID-19 vaccination in the US: matched case-control studySemantic proximity Read

Assessment of Safety and Acceptance toward Covid-19 Vaccines: A cross-sectional Study in EgyptSemantic proximity Read